LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 80

Search options

  1. Article ; Online: Histopathologic features predictive of metastasis and survival in 230 patients with cutaneous squamous cell carcinoma of the head and neck and non-head and neck locations: a single-center retrospective study.

    Farah, M / Milton, D R / Gross, N D / Nagarajan, P / Gu, J / Curry, J L / Ivan, D / Torres-Cabala, C A / Myers, J N / Prieto, V G / Aung, P P

    Journal of the European Academy of Dermatology and Venereology : JEADV

    2022  Volume 36, Issue 8, Page(s) 1246–1255

    Abstract: Background: Staging systems for cutaneous squamous cell carcinoma (cSCC) produce inconsistent risk stratification.: Objective: The aim of this study was to identify further prognostic parameters for better stratification.: Methods: We ... ...

    Abstract Background: Staging systems for cutaneous squamous cell carcinoma (cSCC) produce inconsistent risk stratification.
    Objective: The aim of this study was to identify further prognostic parameters for better stratification.
    Methods: We retrospectively analysed the prognostic significance of clinicopathologic parameters of 230 patients who underwent primary excision of invasive cSCC of the head and neck (n = 115) and non-head and non-neck (n = 115) locations. In addition to known high-risk features, we analysed tumour nest shape, invasion pattern, lymphoid response pattern and tumour budding.
    Results: On multivariable analysis, lymphovascular invasion (LVI) and high tumour budding predicted worse disease-specific survival, and ulceration, LVI and high tumour budding predicted worse overall survival. Only ulceration was independently associated with risk of nodal metastasis.
    Conclusion: High tumour budding, LVI and ulceration are independently associated with poor outcome in cSCC and may be used to refine cSCC prognostic stratification, which is crucial to optimize clinical decision and to identify patients who are more likely to benefit from more aggressive interventions or clinical trials.
    MeSH term(s) Carcinoma, Squamous Cell/pathology ; Head and Neck Neoplasms/pathology ; Humans ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Risk Factors ; Skin Neoplasms/pathology ; Squamous Cell Carcinoma of Head and Neck
    Language English
    Publishing date 2022-05-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 1128828-0
    ISSN 1468-3083 ; 0926-9959
    ISSN (online) 1468-3083
    ISSN 0926-9959
    DOI 10.1111/jdv.18147
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated

    Wong, Ka Kit / Shulkin, Barry L / Gross, Milton D / Avram, Anca M

    Clinical diabetes and endocrinology

    2018  Volume 4, Page(s) 20

    Abstract: Objective: To evaluate the success rate of therapeutic administration of a single calculated : Methods and materials: Patients with Graves' hyperthyroidism underwent pinhole thyroid imaging, 24-h radioactive iodine uptake (RAIU) measurements and ... ...

    Abstract Objective: To evaluate the success rate of therapeutic administration of a single calculated
    Methods and materials: Patients with Graves' hyperthyroidism underwent pinhole thyroid imaging, 24-h radioactive iodine uptake (RAIU) measurements and clinical examination and received a calculated
    Results: The study included 316 hyperthyroid patients with Graves' disease (F238:M78, mean age 42.1 ± 16 y, 4-94). 179 patients (56.6%) had no prior therapeutic intervention (treatment-naive patients), whereas 6 patients had prior thyroid surgery, and 131 (41.5%) had been treated with anti-thyroid medications.The mean estimated thyroid gland size was 50.2 g ± 18, range 15-100. Mean RAIU was 0.57 ± 0.17 (normal 0.07-0.30). RAI doses ranged from 5 to 70 mCi (mean dose = 18.1 mCi). Successful treatment of hyperthyroidism at our institution was obtained after a single therapeutic 131-I activity administration in 295 of 316 (93.3%) patients. Multivariate logistic regression analysis demonstrated that failure of
    Conclusion: Successful
    Language English
    Publishing date 2018-11-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 2834859-X
    ISSN 2055-8260
    ISSN 2055-8260
    DOI 10.1186/s40842-018-0071-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The impact of infection and inflammation in oncologic

    Rahman, W Tania / Wale, Daniel J / Viglianti, Benjamin L / Townsend, Danyelle M / Manganaro, Matthew S / Gross, Milton D / Wong, Ka Kit / Rubello, Domenico

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2019  Volume 117, Page(s) 109168

    Abstract: Sites of infection and inflammation can be misleading in oncology PET/CT imaging because these areas commonly ... ...

    Abstract Sites of infection and inflammation can be misleading in oncology PET/CT imaging because these areas commonly show
    MeSH term(s) Animals ; Fluorodeoxyglucose F18/chemistry ; Fluorodeoxyglucose F18/metabolism ; Humans ; Infections/diagnostic imaging ; Inflammation/diagnostic imaging ; Neoplasms/diagnostic imaging ; Positron Emission Tomography Computed Tomography
    Chemical Substances Fluorodeoxyglucose F18 (0Z5B2CJX4D)
    Language English
    Publishing date 2019-07-01
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2019.109168
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Synchronous Metastatic Breast Carcinoma and Parathyroid Adenoma on 18F-FDG PET/CT and 99mTc-Sestamibi Imaging.

    Singh, Harkamal / Wale, Daniel J / Wong, Ka Kit / Gross, Milton D / Viglianti, Benjamin L

    Clinical nuclear medicine

    2018  Volume 44, Issue 2, Page(s) 148–149

    Abstract: In addition to nuclear cardiac and breast imaging, Tc-sestamibi scintigraphy is often used to localize parathyroid adenomas. F- fluorodeoxyglucose (FDG) PET is heavily utilized in oncology, although its use in identifying parathyroid adenomas is limited. ...

    Abstract In addition to nuclear cardiac and breast imaging, Tc-sestamibi scintigraphy is often used to localize parathyroid adenomas. F- fluorodeoxyglucose (FDG) PET is heavily utilized in oncology, although its use in identifying parathyroid adenomas is limited. We describe a case of a 57-year-old woman who underwent parathyroid scintigraphy and F-FDG PET/CT in the same week due to hyperparathyroidism and an enlarging breast mass, respectively. A right paratracheal mediastinal mass that otherwise would be suspicious for nodal metastases by CT alone was correctly identified to be an ectopic parathyroid adenoma using a combination of the nuclear medicine studies performed.
    MeSH term(s) Adenoma/diagnostic imaging ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/pathology ; Female ; Fluorodeoxyglucose F18 ; Humans ; Middle Aged ; Neoplasm Metastasis ; Neoplasms, Multiple Primary/diagnostic imaging ; Parathyroid Neoplasms/diagnostic imaging ; Positron Emission Tomography Computed Tomography ; Technetium Tc 99m Sestamibi
    Chemical Substances Fluorodeoxyglucose F18 (0Z5B2CJX4D) ; Technetium Tc 99m Sestamibi (971Z4W1S09)
    Language English
    Publishing date 2018-11-12
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 197628-x
    ISSN 1536-0229 ; 0363-9762
    ISSN (online) 1536-0229
    ISSN 0363-9762
    DOI 10.1097/RLU.0000000000002380
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma.

    Wale, Daniel J / Viglianti, Benjamin L / Gross, Milton D / Ferretti, Alice / Rubello, Domenico / Wong, Ka Kit

    American journal of clinical oncology

    2018  Volume 42, Issue 1, Page(s) 99–106

    Abstract: Painful osseous metastasis resulting from castration-resistant prostate carcinoma is a common clinical problem. Historically, nuclear medicine offered several palliative beta-emitting radiopharmaceuticals targeting the skeleton with the goal of ... ...

    Abstract Painful osseous metastasis resulting from castration-resistant prostate carcinoma is a common clinical problem. Historically, nuclear medicine offered several palliative beta-emitting radiopharmaceuticals targeting the skeleton with the goal of decreasing pain. However, these have largely been replaced by the alpha-emitting agent 223radium (Ra). 223Ra received Food and Drug Administration approval in 2013 for the treatment of metastatic castration-resistant prostate cancer with symptomatic bone metastases without visceral metastases. 223Ra offers an improved therapeutic profile due to its alpha-particle emissions resulting in a relatively higher linear energy transfer and lower particle range compared with beta-emitters. 223Ra also has demonstrated to increase overall survival in patients and to delay adverse skeletal events. Running a successful clinical nuclear therapy program with Ra requires a multidisciplinary team approach and this article suggests an implementation strategy from the authors' institution. Potential new nuclear radiopharmaceuticals still under investigation offering the future possibility of radioligand therapy are also discussed briefly.
    MeSH term(s) Bone Neoplasms/radiotherapy ; Bone Neoplasms/secondary ; Clinical Trials as Topic ; Humans ; Lutetium/therapeutic use ; Male ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/therapy ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/therapy ; Radioisotopes/adverse effects ; Radioisotopes/therapeutic use ; Radiopharmaceuticals/therapeutic use ; Radiotherapy/adverse effects ; Radiotherapy/methods ; Radium/adverse effects ; Radium/therapeutic use
    Chemical Substances Radioisotopes ; Radiopharmaceuticals ; Lutetium (5H0DOZ21UJ) ; Lutetium-177 (BRH40Y9V1Q) ; radium Ra 223 dichloride (RJ00KV3VTG) ; Radium (W90AYD6R3Q)
    Language English
    Publishing date 2018-09-11
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 604536-4
    ISSN 1537-453X ; 0277-3732
    ISSN (online) 1537-453X
    ISSN 0277-3732
    DOI 10.1097/COC.0000000000000479
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Lingual Thyroid Ectopia: Diagnostic SPECT/CT Imaging and Radioactive Iodine Treatment.

    Gandhi, Arpit / Wong, Ka Kit / Gross, Milton D / Avram, Anca M

    Thyroid : official journal of the American Thyroid Association

    2016  Volume 26, Issue 4, Page(s) 573–579

    Abstract: Background: Lingual thyroid is a rare abnormality of thyroid development that is usually treated conservatively with levothyroxine replacement. Rarely, it becomes large enough to cause obstructive symptoms in the oral cavity, requiring definitive ... ...

    Abstract Background: Lingual thyroid is a rare abnormality of thyroid development that is usually treated conservatively with levothyroxine replacement. Rarely, it becomes large enough to cause obstructive symptoms in the oral cavity, requiring definitive treatment.
    Patient findings: This study reports on three patients with lingual thyroid treated with radioactive iodine-131 ((131)I) with successful radioablation of their ectopic thyroid tissues. Measurement of 24-hour radioactive iodine uptake within thyroidal tissues and hybrid single-photon emission computed tomography/computed tomography imaging using either iodine-123 or technetium-99m pertechnetate scans were performed in all patients demonstrating the location and size of lingual thyroid and absence of an orthotopic thyroid gland.
    Summary: The aim of this study was to describe nonsurgical management of obstructive lingual thyroid tissue with (131)I therapy for lingual thyroid radioablation. Patients were prepared with a low-iodine diet and levothyroxine withdrawal prior to radioablation for optimizing (131)I uptake in ectopic thyroid tissues. Hybrid single-photon emission computed tomography/computed tomography measurement of anatomic size of lingual thyroid tissue and radioactive iodine uptake guided the selection of therapeutic doses, resulting in administration of 10.7, 17.5, and 15.4 mCi of (131)I, respectively. There were no post-therapy complications, and clinical follow-up demonstrated resolution of obstructive oropharyngeal symptoms.
    Conclusions: Ectopic lingual thyroid tissue is rarely associated with obstructive oropharyngeal symptoms due to progressive enlargement. Radioiodine therapy with (131)I is an effective treatment modality for ablation of ectopic thyroid tissue as an alternative to surgery.
    MeSH term(s) Adult ; Female ; Humans ; Iodine Radioisotopes/chemistry ; Lingual Thyroid/diagnostic imaging ; Lingual Thyroid/etiology ; Lingual Thyroid/therapy ; Middle Aged ; Single Photon Emission Computed Tomography Computed Tomography ; Sodium Pertechnetate Tc 99m/chemistry ; Thyroid Dysgenesis/diagnostic imaging ; Thyroid Gland/diagnostic imaging ; Thyroid Neoplasms/complications ; Thyroid Neoplasms/diagnostic imaging ; Thyroid Neoplasms/therapy ; Thyroxine/adverse effects ; Treatment Outcome ; Young Adult
    Chemical Substances Iodine Radioisotopes ; Sodium Pertechnetate Tc 99m (A0730CX801) ; Thyroxine (Q51BO43MG4)
    Language English
    Publishing date 2016-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1086044-7
    ISSN 1557-9077 ; 1050-7256
    ISSN (online) 1557-9077
    ISSN 1050-7256
    DOI 10.1089/thy.2015.0396
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Contemporary imaging of incidentally discovered adrenal masses.

    Wale, Daniel J / Wong, Ka Kit / Viglianti, Benjamin L / Rubello, Domenico / Gross, Milton D

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2017  Volume 87, Page(s) 256–262

    Abstract: Adrenal lesions are routinely encountered incidentally in clinical practice. Although most of these lesions are benign, malignancy needs to be excluded. Therefore, the initial clinical workup is to exclude aggressive characteristics suggesting malignancy ...

    Abstract Adrenal lesions are routinely encountered incidentally in clinical practice. Although most of these lesions are benign, malignancy needs to be excluded. Therefore, the initial clinical workup is to exclude aggressive characteristics suggesting malignancy and to identify characteristics predictive of the most common benign lesion, an adrenal adenoma. Predicting a benign adenoma using a variety of imaging modalities has been widely studied using unenhanced computed tomography (CT), contrast enhanced CT, and magnetic resonance (MR) imaging. This review article describes the currently used imaging protocols and clinical interpretation criteria of common adrenal lesions. An adenoma can be predicted if a homogenous soft tissue adrenal mass demonstrates low attenuation (upper threshold value of 10 Hounsfield Units) on unenhanced CT, demonstrates an absolute enhancement washout of ≥ 60% and/or relative enhancement washout of ≥ 40% on adrenal washout contrast enhanced CT, or demonstrates signal loss in opposed-phased MR imaging. If an adrenal adenoma cannot be predicted based upon these criteria, the lesion should be evaluated for other imaging characteristics that suggest a specific pathology, such as an adrenal cyst or myelolipoma. Although nonspecific and with limitations, 18F-fluorodeoxyglucose (FDG) PET/CT has a potential role for differentiating benign from malignant lesions based upon the amount of radiopharmaceutical uptake with malignant lesions generally having greater uptake. If clinical and/or hormonal screening suggests a pheochromocytoma, consideration can be given to 18F-dihydroxyphenylalanine (DOPA) or 123I-metaiodobenzylguanidine (MIBG) in addition to CT and MR. Finally, this review proposes a diagnostic work-up strategy for routine use in clinical practice.
    MeSH term(s) Adrenal Gland Neoplasms/diagnostic imaging ; Animals ; Diagnostic Imaging/methods ; Humans ; Incidental Findings ; Magnetic Resonance Imaging/methods ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography/methods ; Radiopharmaceuticals/administration & dosage ; Tomography, X-Ray Computed/methods
    Chemical Substances Radiopharmaceuticals
    Language English
    Publishing date 2017-03
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2016.12.090
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: 99mTc MAG3 renography demonstrating return to normal renal function following resolution of renal vein thrombosis.

    Leschied, Jessica R / Wong, Ka Kit / Gross, Milton D

    Clinical nuclear medicine

    2012  Volume 37, Issue 4, Page(s) 382–384

    MeSH term(s) Female ; Humans ; Kidney/blood supply ; Kidney/physiology ; Middle Aged ; Radioisotope Renography ; Recovery of Function ; Renal Veins/diagnostic imaging ; Technetium Tc 99m Mertiatide ; Venous Thrombosis/diagnostic imaging ; Venous Thrombosis/physiopathology ; Venous Thrombosis/therapy
    Chemical Substances Technetium Tc 99m Mertiatide (36ITO9SKQJ)
    Language English
    Publishing date 2012-04
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 197628-x
    ISSN 1536-0229 ; 0363-9762
    ISSN (online) 1536-0229
    ISSN 0363-9762
    DOI 10.1097/RLU.0b013e318239249f
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Something old, something new, PET in adrenal imaging.

    Gross, Milton D / Rubello, Domenico

    European journal of nuclear medicine and molecular imaging

    2008  Volume 35, Issue 7, Page(s) 1233–1235

    MeSH term(s) Adrenal Glands/diagnostic imaging ; Adrenal Glands/metabolism ; Carbon Radioisotopes ; Etomidate/analogs & derivatives ; Fluorine Radioisotopes ; Humans ; Positron-Emission Tomography/methods ; Positron-Emission Tomography/trends ; Radiopharmaceuticals ; Steroid 11-beta-Hydroxylase/antagonists & inhibitors
    Chemical Substances Carbon Radioisotopes ; Fluorine Radioisotopes ; Radiopharmaceuticals ; Steroid 11-beta-Hydroxylase (EC 1.14.15.4) ; metomidate (Z18ZYL8Y51) ; Etomidate (Z22628B598)
    Language English
    Publishing date 2008-03-13
    Publishing country Germany
    Document type Editorial
    ZDB-ID 8236-3
    ISSN 1619-7089 ; 1619-7070 ; 0340-6997
    ISSN (online) 1619-7089
    ISSN 1619-7070 ; 0340-6997
    DOI 10.1007/s00259-008-0717-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis.

    Wong, Ka Kit / Fig, Lorraine M / Gross, Milton D / Dwamena, Ben A

    Nuclear medicine communications

    2015  Volume 36, Issue 4, Page(s) 363–375

    Abstract: Purpose: The aim of the study was to determine the diagnostic utility of parathyroid scintigraphy with technetium-99m (99mTc)-sestamibi single-photon emission computed tomography/computed tomography (SPECT/CT) for localization of parathyroid adenoma.: ...

    Abstract Purpose: The aim of the study was to determine the diagnostic utility of parathyroid scintigraphy with technetium-99m (99mTc)-sestamibi single-photon emission computed tomography/computed tomography (SPECT/CT) for localization of parathyroid adenoma.
    Materials and methods: We performed a systematic search of medical databases PubMed and Medline/OVID for literature on 99mTc-sestamibi SPECT/CT parathyroid scintigraphy, using the search terms hyperparathyroidism, parathyroid adenoma/hyperplasia, SPECT/CT, and SPECT-CT. Citations for 981 articles and 128 abstracts of full articles were reviewed by two coauthors for relevance. Twenty-four peer-reviewed studies on SPECT/CT parathyroid scintigraphy qualified for inclusion. The Quality Assessment of Diagnostic Accuracy Studies-2 tool was used to assess study quality. Meta-analytical techniques were used to obtain pooled estimates of the parathyroid adenoma localization rate using a random-effects model.
    Results: A total of 24 studies published between January 2003 and March 2014 with 1276 patients (334 men, 762 women, and 180 of unspecified sex) met the inclusion criteria. Data on the test performance of dual-phase 99mTc-sestamibi SPECT/CT showed an estimated pooled sensitivity (per-patient analysis) of 0.86 [confidence interval (CI) 0.81-0.90]. Sensitivity of SPECT/CT was superior to that of SPECT (0.74; CI 0.66-0.82) and planar (0.70; CI 0.61-0.80) techniques. Heterogeneity was present in the reported literature (I2=80.3%). The rate of ectopic parathyroid adenomas ranged between 4 and 20% and SPECT/CT was superior to SPECT and planar imaging for localization of ectopic sites.
    Conclusion: Utilization of SPECT/CT fusion imaging for 99mTc-sestamibi parathyroid scintigraphy improves the test performance compared with planar and SPECT imaging; it assists preoperative planning for a minimally invasive surgical approach for the neck and is of value in subgroups with ectopic glands or coexisting nodular thyroid disease.
    MeSH term(s) Adenoma/diagnostic imaging ; Humans ; Multimodal Imaging ; Parathyroid Neoplasms/diagnostic imaging ; Technetium Tc 99m Sestamibi ; Tomography, Emission-Computed, Single-Photon/methods ; Tomography, X-Ray Computed/methods
    Chemical Substances Technetium Tc 99m Sestamibi (971Z4W1S09)
    Language English
    Publishing date 2015-04
    Publishing country England
    Document type Journal Article ; Meta-Analysis
    ZDB-ID 758141-5
    ISSN 1473-5628 ; 0143-3636
    ISSN (online) 1473-5628
    ISSN 0143-3636
    DOI 10.1097/MNM.0000000000000262
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top